lCritical Illness, Brain Dysfunction, and Survivorship Center (CIBS), Division of Allergy, Pulmonary, and Critical Care Medicine, Department of Medicine at Vanderbilt University Medical Center, ...
zDivision of Hematology, Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy aaDepartment of Precision and Regenerative Medicine and Ionian Area, Aldo Moro ...
If approved, upadacitinib is expected to be the first systemic medication for patients with non-segmental vitiligo, addressing important treatment needs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results